
|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Helicobacter pylori Eradication and Screening
- Volume 4
- Issue 5 Suppl
Is Curing Peptic Ulcer Disease an Oxymoron? A Focus on Helicobacter pylori
Author(s)William R. Garnett, PharmD
Advertisement
Articles in this issue
almost 28 years ago
Participating Facultyalmost 28 years ago
The Impact of H Pylori Eradication on Your Pharmacy Budgetalmost 28 years ago
Overview of H pylori in Peptic Ulcer Diseasealmost 28 years ago
Clinical Issues and Cost Effectiveness of Treating H pylorialmost 28 years ago
Current Issues in H pylori Eradicationalmost 28 years ago
CPE Quizalmost 28 years ago
Selected Abstractsalmost 28 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer
2
3-Year EPCORE NHL-1 Data Published Showing 53% Have Deep, Durable Remission
3
Screening Delays, Overlooked Symptoms Worsen CRC Outcomes in Younger Adults: Jordan Karlitz, MD
4
Bringing Academic Oncology Best Practices to Community Care: Anasuya Gunturi, MD, PhD
5

















